Latest Earnings Results: Q2 '26
Estimated EPS
$1.11
Reported EPS
$1.38
Surprise
+24.32%
Estimated Rev
$337.6M
Reported Rev
$343.49M
Surprise
+1.75%
• Reported GAAP EPS of $0.77 up 11.59% YoY • Reported revenue of $343.49M up 0.33% YoY
Bullish Takeaway
CONMED Corporation achieved gross profit growth driven by strong orthopedic surgery sales and benefited from significant IEEPA tariff refunds, improving overall profitability margins during the second quarter of 2026.
Bearish Takeaway
CONMED Corporation experienced increased selling and administrative expenses, a loss on the sale of gastroenterology assets, and continued margin pressure from inflationary costs and supply chain constraints during the quarter.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.00 | -- | -- | N/A |
Q2 '26 | $1.11 | $1.38 | 24.32% | BEAT |
Q1 '26 | $0.82 | $0.89 | 8.72% | BEAT |
Q4 '25 | $1.32 | $1.43 | 8.01% | BEAT |
Q3 '25 | $1.05 | $1.08 | 2.86% | BEAT |